U.S. markets closed

Wuhan General Group (China), Inc. (WUHN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4650-0.0050 (-1.06%)
At close: 3:41PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4700
Open0.4849
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4627 - 0.5280
52 Week Range0.1700 - 1.0900
Volume56,714
Avg. Volume34,946
Market Cap3.053M
Beta (5Y Monthly)2.52
PE Ratio (TTM)N/A
EPS (TTM)-0.3480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    Lesotho Government Supports M2Bio Sciences Blockchain Initiatives

    CAPE TOWN, SA / ACCESSWIRE / June 2, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:The Lesotho Government has lent its official support to two blockchain initiatives being implemented by M2Bio Sciences.

  • Wuhan General Group Appoints Robert "Black Tiger" Simbowe as Director of Health and Fitness
    ACCESSWIRE

    Wuhan General Group Appoints Robert "Black Tiger" Simbowe as Director of Health and Fitness

    CAPE TOWN, SA / ACCESSWIRE / May 24, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:The company is pleased to announce the appointment of Robert Simbowe as Director of Health and Fitness.

  • ACCESSWIRE

    Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

    CAPE TOWN, SA / ACCESSWIRE / May 20, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:The company is pleased to announce the appointment of Michael Sachar as CEO of M2Bio Sciences Food & Beverage.